Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and pi103

vatalanib has been researched along with pi103 in 5 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(pi103)		Trials
(pi103)		Recent Studies (post-2010) (pi103)
27642981810139

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)pi103 (IC50)
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59FDrosophila melanogaster (fruit fly)2.3
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59FDrosophila melanogaster (fruit fly)2.3
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59FDrosophila melanogaster (fruit fly)2.3
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59FDrosophila melanogaster (fruit fly)2.3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0155
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alphaHomo sapiens (human)1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit betaHomo sapiens (human)0.0585
Cytochrome P450 1A2Homo sapiens (human)0.012
Cytochrome P450 3A4Homo sapiens (human)0.0111
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.011
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.011
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.011
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.0114
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.2038
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0346
Serine/threonine-protein kinase mTORHomo sapiens (human)0.4746
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.069
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.0215
Rapamycin-insensitive companion of mTORHomo sapiens (human)0.083
Regulatory-associated protein of mTORHomo sapiens (human)0.02
Target of rapamycin complex 2 subunit MAPKAP1Homo sapiens (human)0.083
Target of rapamycin complex subunit LST8Homo sapiens (human)0.041

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Russu, WA; Shallal, HM1
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1

Other Studies

5 other study(ies) available for vatalanib and pi103

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
A quantitative analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2008, Volume: 26, Issue:1

    Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship

2008
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship

2011
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011